The way forward for Ketamine and Mood Disorders In 2019, the FDA and European Commission authorised the use of an esketamine nasal spready beneath the brand name title Spravato to deal with depression. However, as of 2021, ketamine hasn't been permitted because of the FDA to take care of despair or other psychological well being disorders, and so,